Advanced search
Publication Cover
Acta Cardiologica Volume 79, 2024 - Issue 3
Submit an article Journal homepage
41
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Comparison of de novo implantation vs. upgrade cardiac resynchronisation therapy: a multicentre experience

Zahra Zandia Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Masoud Eslamib Cardiology Department, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
,
Farzad Kamalia Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Zahra Teimouri-jervekanic Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
,
Mehdi Taherpourd Department of Cardiac Electrophysiology, Razavi Hospital, Imam Reza International University, Mashhad, Iran
,
Reza Mollazadehb Cardiology Department, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
,
Majid Haghjooa Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Amir Farjam Fazelifara Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Abolfath Alizadeha Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Shabnam Madadia Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Sajjad Hosseini Selki Sarb Cardiology Department, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
&
Zahra Emkanjooa Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
 show all
Pages 338-343 | Received 22 Jan 2022, Accepted 14 Nov 2023, Published online: 30 Nov 2023

References

  • Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596–2603. doi:10.1161/01.CIR.0000096580.26969.9A.
  • Steffen MM, Osborn JS, Cutler MJ. Cardiac implantable electronic device therapy: permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices. Med Clin North Am. 2019;103(5):931–943. doi:10.1016/j.mcna.2019.04.005.
  • Boriani G, Nesti M, Ziacchi M, et al. Cardiac resynchronization therapy: an overview on guidelines. Heart Fail Clin. 2017;13(1):117–137. doi:10.1016/j.hfc.2016.07.010.
  • Moskovitch J, Voskoboinik A. Cardiac resynchronization therapy: a comprehensive review. Minerva Med. 2018;110(2):121–138. doi:10.23736/S0026-4806.18.05861-5.
  • Leyva F, Zegard A, Patel K, et al. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2018;41(3):290–298. doi:10.1111/pace.13287.
  • Kosiuk J, Krause M, Doering M, et al. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT. Heart Vessels. 2020;35(1):104–109. doi:10.1007/s00380-019-01449-3.
  • Sideris S, Poulidakis E, Aggeli C, et al. Upgrading pacemaker to cardiac resynchronization therapy: an option for patients with chronic right ventricular pacing and heart failure. Hellenic J Cardiol. 2014;55(1):17–23.
  • Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012;60(14):1297–1313. doi:10.1016/j.jacc.2012.07.009.
  • Ter Horst IA, Kuijpers Y, Van’t Sant J, et al. “Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience. Neth Heart J. 2016;24(1):75–81. doi:10.1007/s12471-015-0771-9.
  • Nemer DM, Patel DR, Madden RA, et al. Comparative analysis of procedural outcomes and complications between de novo and upgraded cardiac resynchronization therapy. JACC Clin Electrophysiol. 2021;7(1):62–72. doi:10.1016/j.jacep.2020.07.022.
  • Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Fail Rev. 2018;23(1):15–26. doi:10.1007/s10741-017-9652-1.
  • Linde CM, Normand C, Bogale N, et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail. 2018;20(10):1457–1468. doi:10.1002/ejhf.1235.
  • Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–1561. doi:10.1161/CIRCULATIONAHA.110.976076.
  • Vamos M, Erath JW, Bari Z, et al. Effects of upgrade versus de novo cardiac resynchronization therapy on clinical response and long-term survival: results from a multicenter study. Circ Arrhythm Electrophysiol. 2017;10(2):e004471. doi:10.1161/CIRCEP.116.004471.
  • Gwag HB, Chun KJ, Hwang JK, et al. Comparison of de novo versus upgrade cardiac resynchronization therapy; focused on the upgrade for pacing-induced cardiomyopathy. Yonsei Med J. 2017;58(4):703–709. doi:10.3349/ymj.2017.58.4.703.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.